Screener
Monopar Therapeutics MNPR Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Monopar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Monopar Therapeutics’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 2:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-016982
| Line item | March 31, 2026 | December 31, 2025* |
|---|---|---|
| Investments | 84,948,677 | 78,565,491 |
| Other current assets | 250,903 | 63,745 |
| Total current assets | 137,743,843 | 140,462,788 |
| Operating lease right-of-use asset | 239,882 | 254,921 |
| Total assets | $137,983,725 | $140,717,709 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable, accrued expenses and other current liabilities | $2,457,748 | $2,735,236 |
Document
FAQ
- What is Monopar Therapeutics's operating lease ROU assets?
- Monopar Therapeutics (MNPR) reported operating lease ROU assets of $239.88K in Q1 2026.
- How has Monopar Therapeutics's operating lease ROU assets changed year-over-year?
- Monopar Therapeutics's operating lease ROU assets increased by 2535.5% year-over-year, from $9.1K to $239.88K.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Monopar Therapeutics's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude